Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma

Figure 1 One-, 3-, and 5-year overall survival of patients in the liver resection group was 86. 2%, 62.8%, and 44.0%, respectively, and 88.3%, 59.8%, and 40.6%, respectively, for patients in the transarterial chemoembolization group. The long-term outcomes of the two groups were similar. TACE: Transarterial chemoembolization.